Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution-Reference-Cited by-同舟云学术

Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution

Published:2016-09 Issue:3 Volume:15 Page:e109-e115
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Kotani Daisuke,Shitara Kohei,Kawazoe Akihito,Fukuoka Shota,Kuboki Yasutoshi,Bando Hideaki,Okamoto Wataru,Kojima Takashi^ORCID,Doi Toshihiko,Ohtsu Atsushi,Yoshino Takayuki

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference22 articles.

1. GLOBOCAN,2012

2. CALGB/SWOG 80405: phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab for patients w/KRAS wild-type untreated metastatic adenocarcinoma of the colon or rectum;Venook;J Clin Oncol,2014

3. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

4. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of neutropenia as a predictive factor of the efficacy of trifluridine-tipiracil treatment;Int. Journal of Clinical Pharmacology and Therapeutics;2023-08-01

2. Trifluridine/tipiracil (FTD/TPI) and regorafenib in older patients with metastatic colorectal cancer;Journal of Geriatric Oncology;2023-05

3. Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors;Clinical Colorectal Cancer;2021-12

4. Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center;The Oncologist;2021-10-01

5. Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab;Oncology Letters;2021-09-13